Applied Filters
Pepsi drops litigation against Indian farmers
PepsiCo India is withdrawing its lawsuits against nine farmers in the Gujarat region who it accused of growing a protected variety of potato used to make the company’s ‘Lay’s’ brand of crisps.
Pepsi offers to settle Indian potato dispute amid criticism
PepsiCo India is attempting to settle a lawsuit against four Indian farmers who the food and drink company say infringed its IP by growing a protected variety of potato.
Duane Morris hires Winston & Strawn lawyer
Duane Morris & Selvam has strengthened its IP practice with the addition of John Alison from Winston & Strawn.
WHO to begin working on gene editing research registry
World Health Organization (WHO) experts have called for central registry on human genome editing research is needed, among a committee consensus that it would be irresponsible for any scientist to conduct gene-editing studies in people.
Tough year ahead as generics take bite out of market: Teva
Israel-based Teva has predicted 2019 will be a tough year, with lower revenue and profit, as the company faces generic competition for two of its top-selling drugs.
Pharma group asks USTR to drop India from watch list
The lobby group for India’s pharma industry has asked the US Trade Representative office to remove India from its Priority Watch List of places that have weak enforcement of intellectual property laws.
Chinese national jailed for stealing medical devices tech
A US district court has sentenced a Chinese national to 27 months in federal prison for the theft of trade secrets from two American medical device manufacturers.
Thailand suspends medical marijuana patents
Thailand’s government has suspended all patents for medical marijuana products, a little more than a month after the country’s parliament voted to approve marijuana for medical use and research.
Indian committee advocates compulsory licensing and price caps
Indian pharmaceutical companies should be encouraged to grant compulsory licences and prices of some patented medicines should be capped, an Indian government panel has said.
Gilead announces licence and collaboration deal with Yuhan
Gilead Sciences, a biopharmaceutical company based in the US, has entered into a licensing and collaboration agreement with South Korean healthcare company Yuhan.
